NCT01222650View on ClinicalTrials.gov

A Comparative Study of KSO-0400 in BPH Patients With LUTS

PHASE2CompletedINTERVENTIONAL
Enrollment

400

Participants

Timeline

Start Date

Not specified

Conditions
Benign Prostatic Hyperplasia (BPH)
Interventions
DRUG

KSO-0400

DRUG

KSO-0400

DRUG

Silodosin

DRUG

Placebo

Trial Locations (1)

Unknown

Japan, Kanto Region

Sponsors
All Listed Sponsors
lead

Kissei Pharmaceutical Co., Ltd.

INDUSTRY

NCT01222650 - A Comparative Study of KSO-0400 in BPH Patients With LUTS | Biotech Hunter | Biotech Hunter